For the quarter ending 2026-03-31, PTPI has $4,394,450 in assets. $2,623,135 in debts. $4,352,450 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Prepaid expenses and other current assets | - | - | 63,202 | 75,342 |
| Cash and cash equivalents | 4,352,450 | 5,136,722 | 6,070,266 | 7,321,501 |
| Prepaid expenses and other current assets | 42,000 | 26,876 | - | - |
| Total current assets | 4,394,450 | 5,163,598 | 6,133,468 | 7,396,843 |
| Total assets | 4,394,450 | 5,163,598 | 6,133,468 | 7,396,843 |
| Accounts payable | 133,304 | 83,883 | 421,142 | 970,025 |
| Accrued expenses | 190,634 | 142,486 | 512,029 | 260,624 |
| Accrued series a convertible redeemable preferred payments payable | 2,298,297 | 2,065,475 | 1,829,610 | 1,715,711 |
| Warrant liability | 900 | 900 | 2,600 | 3,600 |
| Total current liabilities | 2,623,135 | 2,292,744 | 2,765,381 | 2,949,960 |
| Total liabilities | 2,623,135 | 2,292,744 | 2,765,381 | 2,949,960 |
| Common stock (par value 0.0001 per share, 7,000,000,000 and 250,000,000 shares authorized at march 31, 2026, and december 31, 2025, respectively 42,372,502 and 42,284,502 issued and outstanding as of march 31, 2026, and december 31, 2025, respectively) | 4,237 | 4,228 | 4,228 | 4,228 |
| Additional paid-in capital | 114,048,890 | 114,161,402 | 114,322,129 | 114,478,202 |
| Accumulated deficit | -112,281,812 | -111,294,776 | -110,958,270 | -110,035,547 |
| Total stockholders' equity | 1,771,315 | 2,870,854 | 3,368,087 | 4,446,883 |
| Total liabilities, temporary equity and stockholders' equity | 4,394,450 | 5,163,598 | 6,133,468 | 7,396,843 |
Petros Pharmaceuticals, Inc. (PTPI)
Petros Pharmaceuticals, Inc. (PTPI)